An image created by researchers at the Koch Institute that shows red nanoparticles carrying MicroRNAs to an aggressive breast tumor is featured in the National Cancer Institute Cancer Close Up project. Washington Post reporter Laurie McGinley explains that the photographs are intended to spark public interest and encourage young people to consider a career in microbiology.
In an article for the Financial Times, Laura Noonan highlights Prof. Andrew Lo’s work investigating how the theories of financial engineering could be used to fight cancer. “In cancer drug development, because the risks of failure are so high, the probability of success goes up quite dramatically if you create a portfolio,” says Lo.
A team of MIT researchers has been selected as the winner of the Koch Institute research-grant pitch competition for their work on developing a diagnostic platform for early-stage leukemia, reports Amanda Hoover for Boston.com. Hoover explains that the diagnostic method would “single out individual cells during blood tests, highlighting those affected by leukemia.”
Washington Post reporter Laurie McGinley writes that Prof. Tyler Jacks, director of the Koch Institute for Integrative Cancer Research, was named to a panel of experts that will advise the Obama administration on the cancer “moonshot” initiative and how to best “tackle some of the most promising but challenging areas in research today.”
MIT researchers have found evidence that there may be windows of opportunity during which drugs are more effective at treating cancer, reports Ariana Eunjung Cha for The Washington Post. "If we know the route to resistance," explains Prof. Michael Hemann, "we can ambush tumor cells."
MIT researchers have uncovered a potential link between a high-fat diet and increased risk of many types of cancer, reports Chukwuma Muanya for The Guardian. Muanya explains that the study “reveals the effect that a high-fat diet has on the biology of stem cells… and how this might make cancer more likely.”
Prof. Paula Hammond speaks with MSNBC’s Andrea Mitchell about why she feels it's imperative that researchers from different disciplines collaborate on cancer research. Hammond explained funding is needed to bring “scientists, clinicians, technologists together in places like the Koch Institute," where people "work collectively toward a cure.”
In an interview with the BBC, Prof. Heidi Williams argues that there should be more incentives for developing cancer prevention techniques and treatments for early-stage cancers. "If you look at drugs that get approved by the FDA, they all tend to be for very late stage cancer patients,” says Williams.
Prof. Phillip Sharp co-authored this piece for Huffington Post about VP Joe Biden’s national cancer research initiative. “The most important thing about collaboration is that it unquestionably saves lives.”
Prof. Paula Hammond speaks with Tom Ashbrook of NPR’s On Point about Vice President Biden’s new cancer initiative. Hammond likens the challenge to “going to the moon and back, it’s creating a permanent space station out there as well that allows us to continue to learn about some of the new approaches.”
Prof. Michael Yaffe speaks with Scott Kirsner of WBUR’s Radio Boston about Vice President Joe Biden’s new cancer initiative. Prof. Yaffe says that the announcement comes at a “golden era for cancer research. We’ve laid the groundwork and we’re poised with incredible technologies, knowledge and understanding of the disease.”
In an article for The Hill, Prof. Phillip Sharp writes about the need for increased funding for cancer research. “Our arsenal against cancer is growing, and more discoveries and therapies are in the pipeline—but these will only be realized if we sustain our efforts,” Sharp writes.
In an article for U.S News & World Report, Alan Mozes writes that MIT researchers have developed a new imaging technique that lights up cancer cells. The technique may “eventually help surgeons remove all of a cancer the first time.”
Researchers from MIT, Duke University Medical Center and Massachusetts General Hospital have developed a technique for lighting up cancer cells, reports Alice Park for TIME. The technique could “help doctors to target radiation therapy to just the right parts of a tumor to kill remaining cancer cells.”
MIT researchers have found that few incentives exist to encourage research on disease prevention, reports Austin Frakt for The New York Times. “R & D on cancer prevention and treatment of early-stage cancer is very socially valuable,” Profs. Heidi Williams and Ben Roin explain, “yet our work shows that society provides private firms…surprisingly few incentives.”